Objective Oral syringes are the preferred method for delivering paediatric enteral drugs; however, little is known about factors affecting accuracy, particularly at volumes <5 mL. We investigated volumetric accuracy for enteral syringes, using commercially available liquid drug formulations with various physicochemical properties at clinically relevant volumes. Design In vitro experiment. Interventions Ten drugs were tested using two syringe brands (Baxa, Medicina) across a range of formulation volumes (0.05-5 mL) and syringe sizes (1-5 mL). Syringe weights (empty and filled) were converted into volume, using known formulation densities. Ten replications were performed for each drug/ syringe/volume combination. Main outcome measures Delivered volume accuracy was expressed as a percentage of intended volume, with the desired range being within ±10%. Results Baxa demonstrated a slight positive bias (excess average volumes delivered) at the smallest volumes for each syringe size, while Medicina had poorer precision (greater variability, analysis of varianceinteractions all p<0.005). From these results, we identified the limit for volume accuracy for each syringe size and brand. Of note, the 1 mL syringe for both brands was inaccurate for delivering volumes ≤0.1 mL. The physicochemical properties of pH (range 2.82-7.45), surface tension (30.2-86.7 mN/m) and viscosity (2-299 mPaS) did not influence error in a discernible pattern. Conclusions Dosing was inaccurate when small volumes were used across all syringe sizes and brands. These reflect volumes used in clinical practice. Administration error could potentially be reduced by (1) clinicians using syringes appropriate to dosing volumes and (2) manufacturers revising formulation concentrations for drugs.
INTRODUCTION
Paediatric medications are administered typically via the oral route, accounting for approximately 60% of hospital prescriptions in children. Although a variety of oral medications are available, liquid dosage forms are the most common, comprising approximately two-thirds of hospital oral administrations. 1 They are appropriate for infants and any child who has difficulty swallowing tablets or capsules. They also provide a means of adjusting the drug dose to patient's weight or surface area. [2] [3] [4] Two main factors with liquid formulations may compromise paediatric drug dosing. The first concerns the preparation of the formulation and includes issues such as uniformity of content of the product when the drug is suspended and not solubilised, unknown bioavailability of extemporaneously prepared products and the use of potentially toxic excipients such as ethanol. The second aspect relates to the accuracy of administration device used; these include measuring spoons, oral droppers, dosing cups and oral syringes. 5 6 The majority of studies indicate that oral syringes provide greater accuracy than other devices, if used correctly. [7] [8] [9] [10] A variety of agencies and publications now recommend syringes as the preferred oral administration device for infants and children, especially when volumes of <5 mL are required, including the British National Formulary for Children, the UK National Service Framework for Children and the Council of Canadian Academies [11] [12] [13] In addition, it is recommended that syringes be specific for oral administration, rather than using those designed for parenteral use. 14 15 In 2007, the UK National Patient Safety Agency issued a safety alert, recommending the use of clearly labelled oral/ enteral syringes that (1) cannot be connected to What is already known on this topic?
▸ At volumes <5 mL, oral syringes are the recommended devices for administering paediatric liquid drug formulations (compared with measuring spoons, oral droppers or dosing cups). ▸ However, a systematic evaluation using clinically relevant drug formulations has only occurred at volumes >5 mL. ▸ Two common syringe brands are used in UK healthcare settings.
What this study adds?
▸ Volumetric error was unacceptable and inconsistent for both syringe brands when small volumes of commonly used drugs were used, relative to syringe size. ▸ The formulation physicochemical properties of pH, surface tension and viscosity did not influence error in a systematic manner. ▸ We have been able to recommend a minimum acceptable drug volume for each syringe size and brand. parenteral lines, (2) are unable to accommodate needles by having female Luer Lock tips and (3) can be differentiated from parenteral syringes via the use of colour, such as purple.
14 This is now standard practice in many UK hospitals. In addition, these syringes are often used in preference to product-specific syringes supplied by the manufacturer as part of the packaging for certain drugs, especially in hospital settings.
Currently, two brands of oral syringes predominate in the UK. Interestingly, two aspects that could potentially compromise accuracy of drug delivery with these syringes in paediatric clinical practice have not been evaluated to our knowledge. The first relates to physicochemical characteristics of liquid formulations for various drugs. Viscosity and surface tension, for example, can affect the dosing accuracy of administration devices; as demonstrated in a study with oral droppers, 16 the European Committee for Medicinal Products for Human Use acknowledged this, recommending that oral administration devices be suitable for drug dosage forms in terms of the characteristics of the liquid. 5 The second aspect is that therapeutic dosing requirements and hence the administered formulation volume can vary greatly in paediatrics. In practice, it can often be difficult to measure, and hence must be rounded to the nearest syringe graduation to provide a practical volume. 17 However, the extent to which dose rounding can take place without clinical consequences depends on the therapeutic window of drugs and the accuracy of administration devices. 18 Administration devices such as oral syringes can further increase the dose variability if they are not suitable for the specific drug/dose; this could lead to underdosing with diminished treatment efficacy or overdosing with potential for toxic effects. 19 With this in mind, the aim of our study was to evaluate the volumetric accuracy of drug delivery using two common oral syringe brands in the UK, over the range of syringe sizes, drug volumes and liquid physicochemical properties (comprising viscosity, surface tension and pH), which mirror clinical paediatric practice.
METHODS
Two common syringe brands which are licensed for enteral administration of drugs that comply with National Patient Safety Agency recommendations were evaluated. Medicina syringes presented a wide tip and are of 1, 2.5 and 5 mL capacity (smallest graduations of 0.01, 0.1 and 0.2 mL, respectively), whereas Baxa syringes had a narrower tip and are of 1, 3 and 5 mL capacity, and they present the same smallest graduations as the Medicina brand per syringe size (see online supplementary figure 1S).
Materials
Ten oral liquid medicinal products were selected as representative of the formulations used in paediatric clinical practice, encompassing a broad range of viscosity, pH and surface tension. These were classified into ▸ aqueous liquid (calcium carbonate BP suspension-Guy's and St Thomas' NHS Foundation Trust; amoxicillin sugarfree suspension 125 mg/5 mL-Athlone Laboratories; peppermint water BP 1973-Viridian Pharma; Nifedipine oral drops-Ratiopharm; and deionised water as control); ▸ hydroalcoholic liquid (digoxin elixir, Lanoxin; sodium iron edetate elixir, Sytron; alfacalcidol oral drops, One-Alpha; phenytoin suspension, Epanutin); ▸ lipidic liquid (ciclosporin solution, Neoral; ciprofloxacin suspension, Ciproxin).
The pH was measured with a pH metre 209 Hanna. A rotational rheometre (Gemini HR Nano by Malvern) was used to derive the viscosity at a shear rate at 100 s −1 . Various geometries were used, including: (1) cone 2°angle, plate 55 mm, fixed gap of 70 microm for thinner runny liquids; (2) cone 4°angle, plate 40 mm, fixed gap of 150 micrometer for thinner runny liquids and (3) a parallel plate 400 mm, fixed gap of 100 micrometer for ciprofloxacin. Surface tension measurements were carried out on a Delta-8 multichannel microtensiometre (Kibron). Baseline measurements of the physicochemical properties for each formulation ( pH, viscosity and surface tension) were made at room temperature in triplicate.
Measurements of volume accuracy
Ten measurements were made for each combination of syringe brand, syringe size, type of drug and formulation volume. The results are expressed as mean percentage (±SD) of the expected capacity indicated by the graduations. Accurate dosing was defined as within 10% of the intended volume. 17 20 The weight of the syringes' content was measured with a Balance Precisa 180A (accuracy of 0.002 g, with readability and repeatability of 0.1 mg and linearity of 0.2 mg) by subtracting the weight of the filled syringe and the weight of the syringe after expelling the liquid.
This weight was then converted into volume using the density: density ðg=mL) ¼ mass ðgÞ=volume ðmLÞ
The density was determined experimentally (n=3) at room temperature for all liquids by weighing 5 mL in a clean and dry tarred measuring cylinder (capacity 10 mL).
All 10 drug formulations were measured in the 1 mL syringes. Six formulations (Lanoxin, Amoxicillin, Ciproxin, Peppermint water, Calcium Carbonate BP, Sytron) were measured in the medium-sized syringes (2.5 and 3 mL), and only five medicines (Amoxicillin, Ciproxin, Peppermint water, Calcium Carbonate BP, Sytron) were measured with the largest syringe size (5 mL). Water was used as control. This was in order to mimic clinical doses administered in practice. Online electronic supplementary table 1S describes the range of volumes measured for each syringe size.
Statistical analyses
Unadjusted data are expressed as mean±SD. The relationships between syringe brand, syringe size and formulation volume were evaluated using factorial analysis of variance (ANOVA). Brand, syringe size and formulation volume were treated as categorical variables, and the outcome variable ( percentage of desired volume actually delivered) was modelled as continuous. All two-way and three-way interactions were assessed as part of the ANOVA. This approach was taken to assess whether the relative error between brands differed according to syringe size and volume. To test whether the formulations' physicochemical properties affected accuracy of delivery, we undertook multiple linear regression using the 1 mL syringe size only, testing interactions between formulation volume, brand and each of the physicochemical properties (surface tension, viscosity and pH). Only the 1 mL syringe was used, as this was the only syringe where all drugs were tested, thereby maximising the range of physicochemical properties evaluated. Post hoc differences following ANOVA and regression were evaluated using marginal means with 95% CIs. Analyses were performed using Stata V.13.1 (StataCorp, Texas, USA).
As expected, the dead space differed between brands. Medicina (wider tip) showed approximately double the dead space compared with Baxa (narrower tip) in all syringe sizes: 1 mL (0.11 ±0.01 vs 0.06±0.003, p<0.001), 2.5/3 mL (0.13±0.01 vs 0.06 ±0.01, p<0.001) and 5 mL (0.15±0.02 vs 0.09±0.02, p<0.001). Table 1 shows the physicochemical characteristics of the formulations. The ranges for each property were: pH (2.82-7.45), surface tension (30.2-86.7 mN/m) and viscosity (2-299 mPaS).
In terms of overall volumetric accuracy, all two-way and threeway interactions between brand, syringe size and formulation volume were significant (see online electronic supplementary table 2S). This is shown by the ANOVA-estimated marginal means in figure 1 , whereby the error is not consistent between all combinations of brand, syringe size and formulation volume.
The Medicina syringes showed acceptable (ie, <10%) average volume delivery errors across most combinations of syringe size and formulation volume, apart from an isolated, large underprovision of delivered volume (ie, average negative error of 65% desired volume) when 0.1 mL was used in a 2.5 mL syringe. Of note, the average syringe error for the 1 mL Medicina was acceptable for all volumes, including the smallest volume of 0.05 mL. In comparison, all Baxa syringes provided a trend towards unacceptable overprovision ( positive error) of delivered volumes when smaller formulation volumes were used. Here, the 5 mL syringe overdelivered volume by approximately 30% when 0.25 mL was attempted, the 2.5 mL syringe yielded a similar error when 0.1 mL was delivered and the error for the 1 mL syringe became borderline unacceptable (110%) when 0.1 mL was used.
A limitation of figure 1 is that it provides only an estimation of bias (average error), but not precision. The latter was evaluated using box-and-whisker plots for each syringe size and formulation type, which revealed poorer overall precision for the Medicina brand. By inspecting the range of volume plots for each syringe size in a sequential manner, we were able to define the approximate limits of accuracy for each syringe. Figure 2 shows an example for the 1 mL syringes. For formulation volumes of 0.05 and 0.1 mL, the precision for both syringe brands is inadequate, with many values lying outside of the 100%±10% limits (more so for Medicina). However, at 0.25 mL, the majority of values became acceptable. Figure 3 shows the transition points for accuracy of the 2.5/ 3.0 mL syringes. The limit of accuracy was likely to be at a formulation volume of 0.5 mL for both brands. Interestingly, the Baxa yielded a large, consistently positive error for ciclosporin, at all volumes up to and including 1.0 mL. For the 5 mL syringes, the Medicina demonstrated superior precision, being accurate at formulation volumes of 0.5 mL, compared with 1.0 mL for the Baxa (see online supplementary figure 2S) .
The multiple regression models did not reveal a systematic pattern for error for any of the physicochemical properties (see online supplementary figure 3S), with formulation volume again being the largest determinant of error.
DISCUSSION
We have evaluated in vitro limits of volume accuracy for two brands of oral syringe, when dispensing common paediatric drug formulations. The largest source of error appeared to be related to the chosen dispensing volume relative to syringe size, rather than the physicochemical properties of the drug formulation itself. Also, the type of error varied between the two syringe brands. Medicina exhibited less bias, but poorer precision (ie, repeatability) overall; the latter may have been caused by the larger dead space found in this brand. In comparison, Baxa tended to provide a slight positive bias when smaller volumes were administered relative to each syringe size; however, this was generally small, and the precision (repeatability) was better. Of the two errors, we would suggest that precision is the most important, as minimising precision error will result in less variability when repeated drug doses are administered to individual patients. For each syringe size and brand, there appeared to be a transition point at which errors became unacceptable, which has allowed us to make recommendations for the minimum volume to dispense at each syringe size for both syringe brands (table 2) .
However, these recommendations should be interpreted with some caution for three reasons. First, we did not test small volume increments close to the transition point. For example, it can be seen that when dispensing formulations via the 1 mL syringe (figure 2), volumes of 0.25 mL were acceptable, whereas volumes of 0.1 mL were not. However, it is not known if any volumes of administration between these two values (eg, 0.15, 0.2 mL) are acceptable. Second, one drug, ciclosporin, appeared to exhibit a consistent error (overadministration) for one syringe brand (Baxa) at volumes where other drugs were accurate for this syringe brand (see figure 3) . It is unclear whether this is due to the combination of physicochemical properties not seen with other drugs, or an interaction between a chemical compound and the Baxa syringe not seen with the Medicina brand. Thus, it is unclear if an error of similar magnitude would exist for drugs not evaluated in the present study. Third, we do not know the effect of other factors in the clinical setting. For example, when administered orally, small children may suck on the syringe, thereby increasing drug delivery. Similarly, the effect on volume error of administering these drugs via an enteral feeding tube is unknown.
We chose drugs and volumes to reflect those used in clinical practice. For example, a 5 kg baby prescribed nifedipine at doses of 200 μg/kg would receive volumes of 0.05 mL (UK nifedipine formulation strength 20 mg/mL). From figure 2, this could result in a relative underdosing in >50% of administrations using a Medicina syringe and an overdosing in a similar proportion (though by a smaller amount) using a Baxa syringe. It is unlikely that a similar dosing inaccuracy for an adult formulation would be acceptable in clinical practice.
To our knowledge, there are very few other studies in the public domain comparing accuracy of oral syringes for different small dose volumes and characteristics of oral liquids. Padden Elliott et al conducted a study looking at the influence of viscosity in three different oral devices: oral syringes, cups and droppers. They found that syringes were the most accurate devices in vitro for more highly viscous liquids at a 5 mL volume, and also in an in vivo sample of 320 volunteers from community pharmacies. However, this team did not look into doses smaller than 5 mL; they did not examine physicochemical properties other then density and viscosity; and they only used one brand of syringe. 21 Other studies examining volumes <5 mL have concluded that oral syringes are more accurate than other devices; however, these have tended to concentrate on a limited range of volumes, typically 1.25, 2.5 and 5 mL (equating to one-quarter, one-half and one teaspoon). 10 22 Figure 3 Box-and-whisker plots showing precision for the two syringe brands using 2.5/3 mL syringes at two formulation volumes: 0.25 and 0.5 mL. Baxa are represented as grey boxes with outliers as crosses, and Medicina are white boxes with outliers as open circles. Amox, amoxicillin; Ca Carb, calcium carbonate; Ciproflox, ciprofloxacin; Deion H 2 O, deionised water; Pepp H 2 O, peppermint water; Sytron, sodium iron edentate. One further potential source of error not examined in our study was the effect of rounding when a dose prescription required a number of decimal places beyond what is available on the syringe. For example, a drug dose of 1.26 mL cannot be delivered adequately when the smallest graduation on a syringe is 0.1 mL. This is common in clinical practice. Morecroft and colleagues audited 1599 inpatient prescriptions of oral liquid medicines and discovered that 12.5% could not be given accurately, requiring the use of more than one syringe of different volumes. 23 Thus, we would encourage the pharmaceutical industry, medicines regulators and licensing bodies to mandate the provision of paediatric drug formulations in concentrations that provide adequate dosing volumes to minimise errors across the entire spectrum of paediatric practice.
